Advertisement

Reactions Weekly

, Volume 1710, Issue 1, pp 45–45 | Cite as

Apixaban/prothrombin complex concentrate/rivaroxaban

Various toxicities: 2 case reports
Case report

Reference

  1. Tao J, et al. Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors. Journal of Intensive Care 6: No. 34, 14 Jun 2018. Available from: URL: http://doi.org/10.1186/s40560-018-0303-y - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations